Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  T2 Biosystems Inc    TTOO

T2 BIOSYSTEMS INC (TTOO)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/16/2017 11/17/2017 11/20/2017 11/21/2017 11/22/2017 Date
4.08(c) 3.99(c) 4.05(c) 4.05(c) 4.02(c) Last
98 973 86 175 189 580 148 968 120 127 Volume
+0.74% -2.21% +1.50% 0.00% -0.74% Change
More quotes
Financials ($)
Sales 2017 4,16 M
EBIT 2017 -52,3 M
Net income 2017 -59,3 M
Debt 2017 -
Yield 2017 -
Sales 2018 13,2 M
EBIT 2018 -51,8 M
Net income 2018 -58,2 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 34,6x
Capi. / Sales2018 10,9x
Capitalization 144 M
More Financials
Company
T2 Biosystems, Inc. engages in the development of innovative and proprietary technology platform.It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood,... 
More about the company
Surperformance© ratings of T2 Biosystems Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on T2 BIOSYSTEMS INC
11/20 T2 BIOSYSTEMS : Announces New T2Bacteria RUO Panel Data Presented at AMP 2017
11/20 T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017
11/10 T2 BIOSYSTEMS : Announces Presentation on T2Sepsis Solution at AMP 2017
11/09 T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017
11/07 T2 BIOSYSTEMS, INC. : Results of Operations and Financial Condition, Financial S..
11/03 T2 BIOSYSTEMS : Management's Discussion and Analysis of Financial Condition and ..
11/02 T2 BIOSYSTEMS : reports 3Q loss
11/02 T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Compa..
11/02 T2 BIOSYSTEMS INC : T2 Biosystems, Inc. to Host Earnings Call
11/01 T2 Biosystems to Attend the Canaccord Medical Technologies and Diagnostics Fo..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
11/13 Poor earnings updates keep European shares at seven-week low
11/13 SONOVA : misses sales, profit forecasts as U.S. overhaul bites
11/03 ESSILOR INTERNATIONAL : EU regulators suspend Luxottica, Essilor probe, await da..
11/03DJESSILOR INTERNATIONAL : EU Regulator Has Suspended Essilor, Luxottica Probe -Reu..
11/03 SMITH & NEPHEW : Under pressure Smith & Nephew to focus on efficiency
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
11/02 T2 Biosystems' (TTOO) CEO John McDonough on Q3 2017 Results - Earnings Call T..
11/02 T2 Biosystems beats by $0.04, misses on revenue
11/01 Notable earnings after Thursday?s close
10/18 Premarket analyst action - healthcare
09/15 Midday Gainers / Losers
Chart T2 BIOSYSTEMS INC
Duration : Period :
T2 Biosystems Inc Technical Analysis Chart | TTOO | US89853L1044 | 4-Traders
Technical analysis trends T2 BIOSYSTEMS INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 5,75 $
Spread / Average Target 43%
EPS Revisions
Managers
NameTitle
John P. McDonough President, Chief Executive Officer & Director
Joanne Spadoro Chief Operating Officer
Darlene M. Deptula-Hicks Chief Financial Officer, Senior VP & Treasurer
Thomas Jay Lowery Chief Scientific Officer
Michael A. Pfaller Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
T2 BIOSYSTEMS INC-23.00%144
MEDTRONIC PLC15.60%111 537
BAXTER INTERNATIONAL44.43%34 891
C R BARD INC49.19%24 432
ZIMMER BIOMET HOLDINGS INC10.04%22 894
ALIGN TECHNOLOGY166.75%20 396